ITMI20000095A0 - Cerotto per la somministrazione locale e transdermica di principi attivi dotati di gruppi anionici ed elettronattrattori - Google Patents

Cerotto per la somministrazione locale e transdermica di principi attivi dotati di gruppi anionici ed elettronattrattori

Info

Publication number
ITMI20000095A0
ITMI20000095A0 IT2000MI000095A ITMI20000095A ITMI20000095A0 IT MI20000095 A0 ITMI20000095 A0 IT MI20000095A0 IT 2000MI000095 A IT2000MI000095 A IT 2000MI000095A IT MI20000095 A ITMI20000095 A IT MI20000095A IT MI20000095 A0 ITMI20000095 A0 IT MI20000095A0
Authority
IT
Italy
Prior art keywords
electronattractors
patch
local
active ingredients
transdermal administration
Prior art date
Application number
IT2000MI000095A
Other languages
English (en)
Inventor
Francesco Cilurzo
Francesco Roversi
Original Assignee
A C R Applied Coating Res S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A C R Applied Coating Res S A filed Critical A C R Applied Coating Res S A
Priority to IT2000MI000095A priority Critical patent/IT1317736B1/it
Publication of ITMI20000095A0 publication Critical patent/ITMI20000095A0/it
Priority to AT01911540T priority patent/ATE251453T1/de
Priority to EP01911540A priority patent/EP1253913B1/en
Priority to AU2001240551A priority patent/AU2001240551A1/en
Priority to DE60100937T priority patent/DE60100937D1/de
Priority to PCT/EP2001/000870 priority patent/WO2001054674A1/en
Publication of ITMI20000095A1 publication Critical patent/ITMI20000095A1/it
Application granted granted Critical
Publication of IT1317736B1 publication Critical patent/IT1317736B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT2000MI000095A 2000-01-26 2000-01-26 Cerotto per la somministrazione locale e transdermica di principiattivi dotati di gruppi anionici ed elettronattrattori. IT1317736B1 (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT2000MI000095A IT1317736B1 (it) 2000-01-26 2000-01-26 Cerotto per la somministrazione locale e transdermica di principiattivi dotati di gruppi anionici ed elettronattrattori.
AT01911540T ATE251453T1 (de) 2000-01-26 2001-01-26 Pflaster für die lokale und transdermale verabreichung von wirkstoffen mit anionischen oder elektronen-anziehenden gruppen
EP01911540A EP1253913B1 (en) 2000-01-26 2001-01-26 Patch for local and transdermal administration of active ingredients containing anionic or electron-attracting groups
AU2001240551A AU2001240551A1 (en) 2000-01-26 2001-01-26 Patch for local and transdermal administration of active ingredients containing anionic or electron-attracting groups
DE60100937T DE60100937D1 (de) 2000-01-26 2001-01-26 Pflaster für die lokale und transdermale verabreichung von wirkstoffen mit anionischen oder elektronen-anziehenden gruppen
PCT/EP2001/000870 WO2001054674A1 (en) 2000-01-26 2001-01-26 Patch for local and transdermal administration of active ingredients containing anionic or electron-attracting groups

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000MI000095A IT1317736B1 (it) 2000-01-26 2000-01-26 Cerotto per la somministrazione locale e transdermica di principiattivi dotati di gruppi anionici ed elettronattrattori.

Publications (3)

Publication Number Publication Date
ITMI20000095A0 true ITMI20000095A0 (it) 2000-01-26
ITMI20000095A1 ITMI20000095A1 (it) 2001-07-26
IT1317736B1 IT1317736B1 (it) 2003-07-15

Family

ID=11443775

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000MI000095A IT1317736B1 (it) 2000-01-26 2000-01-26 Cerotto per la somministrazione locale e transdermica di principiattivi dotati di gruppi anionici ed elettronattrattori.

Country Status (6)

Country Link
EP (1) EP1253913B1 (it)
AT (1) ATE251453T1 (it)
AU (1) AU2001240551A1 (it)
DE (1) DE60100937D1 (it)
IT (1) IT1317736B1 (it)
WO (1) WO2001054674A1 (it)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0116659B8 (pt) 2000-11-06 2021-05-25 Samyang Biopharmaceuticals composição para uso em sistema de distribuição transdérmica de droga e sistema de distribuição transdérmica de droga
CA2428181A1 (en) * 2000-11-07 2002-05-16 Hisamitsu Pharmaceutical Co., Inc. Pharmaceutical preparation of percutaneous absorption type
WO2002083790A1 (de) * 2001-04-10 2002-10-24 Creavis Gesellschaft Für Technologie Und Innovation Mbh Bindermittel aus säuregruppen-enthaltenden polymer-kompositionen mit einstellbaren elektrischen und thermischen eigenschaften
ITMI20012827A1 (it) * 2001-12-28 2003-06-28 Fidia Farmaceutici Formulazioni adesive transdermiche di diclofenac sodico
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
DK1877509T3 (da) 2005-03-17 2012-01-23 Pharmafilm S R L Vandigt polymersystem til trykfølsom klæbemiddelmatrixfremstilling
EP1888025B1 (en) * 2005-06-08 2020-08-12 Basf Corporation Medicament carrier composition and method of forming a film therefrom
MX2007015949A (es) 2005-06-17 2008-03-07 Vital Health Sciences Pty Ltd Un vehiculo que comprende uno o mas derivados de fosfato de di- y/o mono-(agentes de transferencia de electrones) o complejos de los mismos.
CN102077060B (zh) 2008-06-04 2014-10-29 G·帕特尔 一种基于腐蚀金属的监测系统
EP2435403A4 (en) * 2009-05-27 2015-04-01 Takeda Pharmaceuticals Usa Inc THIOCOLCHICINE DERIVATIVES AND MANUFACTURING AND USE METHOD THEREFOR
US10071030B2 (en) 2010-02-05 2018-09-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
JP5806287B2 (ja) * 2010-03-30 2015-11-10 フォスファジェニクス リミティド 経皮送達パッチ
WO2012122586A1 (en) 2011-03-15 2012-09-20 Phosphagenics Limited New composition
RU2503445C1 (ru) * 2012-11-22 2014-01-10 Владимир Анатольевич Мазильников Фармацевтическая композиция в виде пасты для защиты кожи
ITUB20153446A1 (it) * 2015-09-07 2017-03-07 Pharmafilm Srl Film orodispersibili a rapida disgregazione per uso terapeutico o alimentare
MX383940B (es) 2015-12-09 2025-03-14 Phosphagenics Ltd Formulación farmacéutica que contiene tocol fosfato.
WO2018006069A1 (en) * 2016-06-30 2018-01-04 Teva Pharmaceuticals International Gmbh Improved formulations for transdermal pharmaceutical systems
JP7198754B2 (ja) 2016-12-21 2023-01-04 アベーチョ バイオテクノロジー リミテッド 方法
BR112020010146A2 (pt) * 2017-12-20 2020-10-13 Lts Lohmann Therapie-Systeme Ag composição frigoestável para fornecimento transdérmico iontoforético de um composto de triptano
JP7404239B2 (ja) * 2017-12-20 2023-12-25 エルテーエス ローマン テラピー－ジステーメ アーゲー トリプタン化合物のイオントフォレーシス経皮送達のための寒冷安定性組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3827561C1 (it) * 1988-08-13 1989-12-28 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
JP3132837B2 (ja) * 1991-02-21 2001-02-05 積水化学工業株式会社 医療用粘着剤
SE9601527D0 (sv) * 1996-04-23 1996-04-23 Pharmacia Ab Transdermally alministered acetylcysteine as mucolytic agent

Also Published As

Publication number Publication date
ATE251453T1 (de) 2003-10-15
ITMI20000095A1 (it) 2001-07-26
IT1317736B1 (it) 2003-07-15
WO2001054674A1 (en) 2001-08-02
DE60100937D1 (de) 2003-11-13
AU2001240551A1 (en) 2001-08-07
EP1253913A1 (en) 2002-11-06
EP1253913B1 (en) 2003-10-08

Similar Documents

Publication Publication Date Title
NO20012915L (no) Ny farmasöytisk formulering
ID22565A (id) Penggunaan nanodispersi dalam formulasi akhir obat
FI19991852L (fi) Uusi monikerroksinen materiaali, joka käsittää vaikuttavan ainesosan, ja sen valmistus
DE69928085D1 (de) Dosierungsform mit verlängerter wirkstoffabgabe
BR0314354A (pt) Formação para gentes lipofìlicos
FI991485A0 (fi) Uusi farmaseuttinen koostumus
EE05383B1 (et) Polarlkarboksamiidhendid,ÁnendeÁvalmistamineÁjaÁkasutamineÁlipiiditasetÁalandavateÁtoimeainetenaÁningÁneidÁsisaldavÁfarmatseutilineÁkompositsioon
EE04452B1 (et) Farmatseutiliselt aktiivne morfolinool ja selle kasutamine
DK1189853T3 (da) Betonformulering
ITTO20010008A0 (it) Formulazione farmaceutica
EE04879B1 (et) Sünteetilised pindaktiivsed peptiidid ja nende kasutamine sünteetilise surfaktandi valmistamiseks
DE60127277D1 (de) Zusammensetzung zur transdermalen und/oder transmukosalen Verabreichung von Wirkstoffen, die ausreichende therapeutische Spiegel garantiert
EE04219B1 (et) Säilituskindel toimeainekontsentraat formoterooliga
AU2002234525A1 (en) Transdermal therapeutic system comprising the active ingredient oxybutynin
LV12624A (lv) Thienylazolylalcoxyethanamines their preparation and their application as medicaments
PL366855A1 (en) Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof
ATE220547T1 (de) Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
IT1319210B1 (it) Pellicola per la somministrazione dermica e transdermica di principiattivi.
DE60001266D1 (de) Betahistin-hältige formulierung mit kontrollierter wirkstofffreisetzung
ID30032A (id) Formulasi farmasi
FR2810540B1 (fr) Nouvelles preparations cosmetiques ou hygieniques sous forme de dispersion
AR025867A1 (es) Formulacion portasdora farmaceutica
NO20004816D0 (no) Ny farmasøytisk formulering
ITFI970072A0 (it) Composti pseudo-peptidici, loro preparazione ed uso in formulazioni farmaceutiche
IT1308583B1 (it) Procedimento di consolidamento per terreni ed edifici.